InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
C6C
1.88%
$3.80
COPPER MOUNTAIN MINING CORPORATION - News & Media
Currently unlisted.
Proposed listing date: FRIDAY, 06 APRIL 2018 12:30 PM AEST #
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
No News & Media currently available.